Cargando…
Transforming growth factor-β signaling in systemic sclerosis
Systemic sclerosis (SSc) is a complex, multiorgan autoimmune disease of unknown etiology. Manifestation of the disease results from an interaction of three key pathologic features including irregularities of the antigen-specific immune system and the non-specific immune system, resulting in autoanti...
Autores principales: | Ayers, Nolan B., Sun, Chen-Ming, Chen, Shi-You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956255/ https://www.ncbi.nlm.nih.gov/pubmed/29353817 http://dx.doi.org/10.7555/JBR.31.20170034 |
Ejemplares similares
-
Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer
por: Kretzschmar, Marcus
Publicado: (2000) -
Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy
por: Chen, Jitang, et al.
Publicado: (2021) -
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
por: Shi, Xueke, et al.
Publicado: (2020) -
Transforming growth factor β signaling in uterine development and function
por: Li, Qinglei
Publicado: (2014) -
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
por: Chan, Max Kam-Kwan, et al.
Publicado: (2023)